PentaGen
FISH probes
FISH probes
FastProbe probes (CE IVD)
HealthCare Biotechnology produces FISH probes for pathology and hemato-oncology, with the main advantage of reduced hybridization time. The probes target non-repetitive sequences, resulting in increased specificity and reduced background signal.
Breast tumors | HER2/CEP17 |
TOP2A/CEP17 | |
MYC/CEP8 | |
Lung tumors | ALK |
ROS1 Break appart | |
C-MET/CEP7 | |
Bladder tumors | CEP3/CEP3 |
p16 | |
p53 | |
Brain tumors | BRAF |
C11orf-95/RELA | |
Aplastic anemia | D7S486/CEP7 |
D20S108/20q13.12 | |
CCND1/CEP11 | |
CEP8 | |
EGR1 del | |
BCL1 Break apart | |
ALL | TEL/AML1 |
IGH Break appart | |
P16/CEP9 | |
CEP4/CEP10 | |
MYC Break apart | |
BCR/ABL | |
CDK2NA/CEP9 | |
KMT2A (MLL) Break apart | |
CEP17 | |
Cervical tumors | TER/CEP3 |
C-MYC/CEP8 | |
CLL | D13S319/LAMP1 |
p53/CEP17 | |
CEP11/ATM | |
RB1/ATM | |
CEP12 | |
MYB/CEP6 | |
Lymphomas | BCL6 Break appart |
IGH Break appart | |
BCL2/IGH | |
MYC gene break | |
BCL2 Break appart | |
C-MYC/IGH | |
P53 | |
CCND1 (BCL1)/IGH | |
CML | BCL2/IGH |
BCR/ABL | |
p53/CEP17 | |
ASS1/CEP9 | |
AML | AML1/ETO |
CBFB | |
CBFB/MYH11 | |
PML/RARA | |
MLL | |
Multiple myeloma | 1q21 |
p53/CEP17 | |
D13S319/LAMP1 | |
RB | |
IGH | |
MDS | EGR1/D5S630 |
D7S486/CEP7 | |
D20S108/CEP8 | |
7q22.1-22.2/q31.2 | |
CSF1R/D5S630 | |
D7S522/CEP7 | |
CEPY/CEPX | |
20q12/20q13.12 |
A complete list of probes is available on request (info@pentagen.hu or diagnostika@pentagen.cz)